---
document_datetime: 2023-09-21 17:39:32
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/erbitux-epar-all-authorised-presentations_en.pdf
document_name: erbitux-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.341092
conversion_datetime: 2025-12-22 17:56:39.402943
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) Number Invented name Strength Pharmaceutical form Route of administration Immediate packaging Content Pack size

EU/1/04/281/003 Erbitux 5 mg/ml Solution for infusion Intravenous use vial (glass) 20 ml 1 vial EU/1/04/281/005 Erbitux 5 mg/ml Solution for infusion Intravenous use vial (glass) 100 ml 1 vial